Stock listing

BM8 Stock Price, News, Filings & Events — Biomarin Pharmaceutical Inc.

Selected listing: BM8 · FWB · EUR · DE

The BM8:FWB listing represents BioMarin Pharmaceutical Inc., a biotechnology company focused on developing innovative therapies for rare genetic diseases. The company is known for its commitment to advancing treatments that address unmet medical needs, and it frequently updates investors on its research progress and clinical trial results. Recent news includes developments in their pipeline and regulatory filings that may impact their market position. Investors can find relevant events and announcements that provide insights into BioMarin's strategic direction and operational milestones.

BM8:FWBEURDEUpdated July 20, 2026
Biomarin Pharmaceutical Inc. logo
Ticker
BM8:FWB
Asset type
Stock
Market cap
$11.40B
Sector
Health Technology
Industry
Biotechnology
Exchange
FWB
Currency
EUR

Biomarin Pharmaceutical Inc. BM8:FWB stock context

The BM8:FWB listing represents BioMarin Pharmaceutical Inc., a biotechnology company focused on developing innovative therapies for rare genetic diseases. The company is known for its commitment to advancing treatments that address unmet medical needs, and it frequently updates investors on its research progress and clinical trial results. Recent news includes developments in their pipeline and regulatory filings that may impact their market position. Investors can find relevant events and announcements that provide insights into BioMarin's strategic direction and operational milestones.

Research Biomarin Pharmaceutical Inc.

Alternate listings